Dorça Alessandra, Alcântara Livia A, Diniz Denise Sisterolli, Sarmet Max, Menezes Mateus Sérgio Ricardo, Franco Oliveira Luis Vicente, Franco Hamilton, Maldaner Vinicius
Department of Speech Sciences, Federal University of Goias, Goias, Brazil.
Post Graduate ProgramHuman Movement and Rehabilitation Program, University Center of Anapolis UniEvangelica, Anapolis, Brazil.
Contemp Clin Trials Commun. 2020 Sep 2;19:100647. doi: 10.1016/j.conctc.2020.100647. eCollection 2020 Sep.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting both upper and lower motor neurons, and lead to respiratory failure. Strategies are suggested to respiratory management in ALS patients, as the breath stacking and Expiratory muscle training (EMT), which have been used as aid to assist cough in neuromuscular disorders. However, the randomized controlled trials performed in ALS patients have not investigated the addiction of EMT together breath stacking in this population. This trial aims to determine if breath stacking plus EMT is more effective than breath stacking alone to decrease the decline rate on the inspiratory/expiratory muscle strength, FVC and voluntary PCF in ALS patients.
This parallel-group, assessor-blinded randomized controlled trial, powered for superiority, aims to assess pulmonary function, respiratory muscle strength, peak cough flow as primary outcomes. Forty-two participants are being recruited referral neuromuscular disease center at Brasilia, Brazil. Following baseline testing, participants are randomized using concealed allocation, to receive either: a) breath stacking technique alone or b) breath stacking technique plus EMT.
There is a lack of evidence regarding the benefit of EMT plus breath stacking in ALS patients. This trial will contribute to evidence currently being generated in national and international trials by implementing and evaluating a respiratory therapy program including two components not yet combined in previous research, for people with ALS involving longer-term follow-up of outcomes. This trial is ongoing and currently recruiting.
This trial was prospectively registered on the Clinical Trials Registry NCT04226144.
肌萎缩侧索硬化症(ALS)是一种进行性神经退行性疾病,会影响上下运动神经元,并导致呼吸衰竭。有人建议对ALS患者进行呼吸管理,如呼吸叠加和呼气肌训练(EMT),这些方法已被用于辅助神经肌肉疾病患者咳嗽。然而,在ALS患者中进行的随机对照试验尚未研究在该人群中EMT与呼吸叠加联合使用的效果。本试验旨在确定呼吸叠加加EMT是否比单独使用呼吸叠加更有效地降低ALS患者吸气/呼气肌力量、用力肺活量(FVC)和自主峰值咳嗽流量(PCF)的下降率。
这项平行组、评估者盲法的随机对照试验旨在评估肺功能、呼吸肌力量、峰值咳嗽流量作为主要结果,具有优越性。目前正在巴西巴西利亚的转诊神经肌肉疾病中心招募42名参与者。在基线测试后,参与者通过隐蔽分配随机分组,接受以下两种治疗之一:a)单独使用呼吸叠加技术;b)呼吸叠加技术加EMT。
关于EMT加呼吸叠加对ALS患者的益处,目前缺乏证据。本试验将通过实施和评估一项呼吸治疗方案,为目前国内外试验中正在产生的证据做出贡献,该方案包括两个在以前的研究中尚未结合的组成部分,针对ALS患者进行长期随访。本试验正在进行中,目前正在招募参与者。
本试验已在临床试验注册中心NCT04226144上进行前瞻性注册。